- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05398315
Interactive Alcohol Decision-Making Programs
Testing the Efficacy of Interactive Alcohol Decision-Making Program
Study Overview
Status
Conditions
Detailed Description
The National Survey on Drug Use and Health estimates that 19.3 million individuals ages 12 and over met criteria for an alcohol use disorder in the past year, fully 87.4% of whom neither received any treatment in the past 12 months, nor wanted it. Recognition of this tremendous gap has led to efforts, both nationally and internationally, to implement proactive screening and brief intervention. Brief interventions have proven efficacious in reducing unhealthy drinking with effect sizes in meta-analyses ranging from small to moderate. Brief interventions are also uniquely applicable to non-treatment-seeking populations, who may refuse extended treatment but accept a minimal, opportunistic intervention. However, the public health impact of brief interventions has been limited by substantial difficulty with implementation. Further, positive overall findings in meta-analyses obscure the results of multiple rigorous efficacy trials showing no brief intervention effect on alcohol use. Both of these issues-the implementation challenges and the inconsistency in outcomes-suggest that changes are needed before brief alcohol interventions can meet their full potential.
Technology offers exciting potential in both respects. First, computer-delivered brief interventions (CDBIs) can be presented inexpensively, with perfect fidelity, and without the need for training or provider time. Second, their replicability, flexibility, and modularity makes them the perfect platform for (a) isolating the active ingredients that are associated with positive outcomes; and thereby (b) continually optimizing CDBIs to achieve cumulative increases in efficacy.
The overall goal of this research is to develop a maximally effective and replicable CDBI for reducing heavy alcohol use. To accomplish this, the investigators will use the Multiphase Optimization Strategy (MOST), an efficient method for optimizing intervention content that uses factorial designs to evaluate main and interaction effects of specific intervention components. The selection of components will be guided by: (a) Common Factors Theory, which highlights the tremendous contribution of relational factors, such as empathy, alliance and positive regard to therapy outcomes, but which is of unknown relevance to CDBIs; and (b) the Media Equation Theory, which suggests that people automatically respond to computers in social ways, particularly when those computers replicate human characteristics. Guided by this literature, the investigators will examine outcomes of a CDBI in which empathic statements, the gender of the narrator, the presence/absence of a narrator backstory, and the use/non-use of motivational interviewing techniques are systematically manipulated using a factorial design.
Specific aims are as follows:
- Develop 16 distinct, time-consistent, computer-delivered sessions representing all possible combinations of the following four factors (each of which will be binary; i.e. either present vs. absent or male vs. female): (1) narrator gender, (2) empathic statements and reflections, (3) narrator backstory, and (4) use of motivational techniques.
- Evaluate main and interaction effects of the five factors by randomly assigning 352 heavy drinkers to the 16 sessions (each of the four factors being presented to half of the participants) and evaluating (1) subjective reactions to the CDBI at baseline and (2) alcohol use at 1-month follow-up.
Hypothesis 1. Subjective reactions to the CDBI, disclosure of alcohol use and consequences, and motivation to reduce alcohol use will be higher and alcohol use at follow-up will be lower in the presence of (1) empathic statements, (2) a narrator backstory and (3) motivational techniques. The effects of narrator gender will be examined in an exploratory way (i.e., no a priori hypotheses).
Hypothesis 2. Subjective reactions will be more positive, disclosure and motivation to reduce alcohol use will be higher, and alcohol use at follow-up will be lower when the two relational factors (empathy and narrator backstory) are combined with the presence of motivational content.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48202
- Wayne State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Over age 18
- Access to the internet.
- Males must consume at least 14 drinks per week or 4 drinks per day
- Females must consume at least 7 drinks per week or 3 drinks per day
Exclusion Criteria:
- Under age 18
- No internet access
- Males who consume less than 14 drinks per week or 4 drinks per day
- Females who consume less than 7 drinks per week or 3 drinks per day
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Empathic Statements, MI, Male, No Backstory
Presence of empathic statements and MI techniques.
Male narrator.
No narrator backstory.
|
Presence of Empathic Statements
Presence of a male narrator
Presence of MI techniques
|
|
Experimental: No Empathic Statements, No MI, Female, No Backstory
No empathic statements, MI techniques or narrator backstory.
Female narrator
|
Presence of a female narrator
|
|
Experimental: No Empathic Statements, No MI, Female, Backstory
No empathic statements or MI techniques.
Presence of narrator backstory.
Female narrator
|
Presence of a female narrator
Presence of a narrator backstory
|
|
Experimental: Empathic Statements, MI, Female, Backstory
Presence of empathic statements, MI techniques and narrator backstory.
Female narrator
|
Presence of Empathic Statements
Presence of MI techniques
Presence of a female narrator
Presence of a narrator backstory
|
|
Experimental: No Empathic Statements, No MI, Male, No Backstory
No empathic statements, MI techniques or narrator backstory.
Male narrator
|
Presence of a male narrator
|
|
Experimental: Empathic Statements, MI, Male, Backstory
Presence of empathic statements, MI techniques and narrator backstory.
Male narrator.
|
Presence of Empathic Statements
Presence of a male narrator
Presence of MI techniques
Presence of a narrator backstory
|
|
Experimental: No Empathic Statements, MI, Female, Backstory
Presence of MI techniques and narrator backstory.
No empathic statements.
Female narrator.
|
Presence of MI techniques
Presence of a female narrator
Presence of a narrator backstory
|
|
Experimental: Empathic Statements, No MI, Male, No Backstory
Presence of empathic statements.
No MI techniques or narrator backstory.
Male narrator.
|
Presence of Empathic Statements
Presence of a male narrator
|
|
Experimental: No Empathic Statements, MI, Male, Backstory
Presence of MI techniques and narrator backstory.
No empathic statements.
Male narrator.
|
Presence of a male narrator
Presence of MI techniques
Presence of a narrator backstory
|
|
Experimental: Empathic Statements, No MI, Female, No Backstory
Presence of empathic statements.
No MI techniques or narrator backstory.
Female narrator.
|
Presence of Empathic Statements
Presence of a female narrator
|
|
Experimental: Empathic Statements, MI, Female, No Backstory
Presence of empathic statements and MI techniques.
Female narrator.
No narrator backstory.
|
Presence of Empathic Statements
Presence of MI techniques
Presence of a female narrator
|
|
Experimental: No Empathic Statements, No MI, Male, Backstory
Presence of narrator backstory.
No empathic statements or MI techniques.
Male narrator.
|
Presence of a male narrator
Presence of a narrator backstory
|
|
Experimental: Empathic Statements, No MI, Female, Backstory
Presence of empathic statements and narrator backstory.
No MI techniques.
Female narrator.
|
Presence of Empathic Statements
Presence of a female narrator
Presence of a narrator backstory
|
|
Experimental: Empathic Statements, No MI, Male, Backstory
Presence of empathic statements and narrator backstory.
No MI techniques.
Male narrator.
|
Presence of Empathic Statements
Presence of a male narrator
Presence of a narrator backstory
|
|
Experimental: No Empathic Statements, MI, Female, No Backstory
Presence of MI techniques.
No empathic statements or narrator backstory.
Female narrator.
|
Presence of MI techniques
Presence of a female narrator
|
|
Experimental: No Empathic Statements, MI, Male, No Backstory
Presence of MI techniques.
No empathic statements or narrator backstory.
Male narrator.
|
Presence of a male narrator
Presence of MI techniques
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Quantity and Frequency of Alcohol Use
Time Frame: Given pre-intervention and at 1-month follow-up
|
The Timeline Followback Questionnaire (TLFB) will be given to assess past month alcohol use.
|
Given pre-intervention and at 1-month follow-up
|
|
Change in Alcohol-Related Consequences
Time Frame: Given pre-intervention and at 1-month follow-up
|
Assessed with the Brief Young Adult Alcohol Consequences Questionnaire which assess the occurrence/ non-occurrence of 24 alcohol consequences.
|
Given pre-intervention and at 1-month follow-up
|
|
Participant Satisfaction with the Intervention
Time Frame: Given immediately after completing the intervention
|
Fifteen item measure assessing how much participants liked the intervention and felt respected by it.
|
Given immediately after completing the intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Emily Grekin, PhD, Wayne State University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 22-01-4352
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heavy Drinking
-
Cambridge Health AllianceRecruiting
-
The National Center on Addiction and Substance...Not yet recruitingHeavy Drinking
-
Centre for Addiction and Mental HealthCompleted
-
RANDUniversity of Southern CaliforniaRecruiting
-
University of California, Los AngelesNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedHeavy Drinking
-
University of HoustonCompletedHeavy DrinkingUnited States
-
University of HoustonCompleted
-
Peking University Sixth HospitalNot yet recruiting
-
Central Institute of Mental Health, MannheimCompletedHeavy DrinkingGermany
-
University of MemphisCompletedHeavy DrinkingUnited States
Clinical Trials on Empathic Statements/Reflections
-
Juliana de Lima LopesCompleted
-
Kahramanmaras Sutcu Imam UniversityCompleted
-
Federal University of São PauloCompletedCardiovascular DiseaseBrazil
-
Istanbul UniversityNot yet recruitingProcedural Pain | Procedural Anxiety | Breast Imaging
-
Kanuni Sultan Suleyman Training and Research HospitalRecruiting
-
Southern Methodist UniversityRecruitingDepression | Anhedonia | MoodUnited States
-
Jewish General HospitalCompleted
-
London School of Economics and Political ScienceHarvard Medical School / Harvard Pilgrim Health Care InstituteCompleted
-
University of AlbertaAlberta Health & Wellness; Merck Frosst Canada Ltd.; Canadian Diabetes Association and other collaboratorsCompletedHypertension | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Canada